3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
104
Neoplasms
13
Neoplasm Metastasis
8
Sarcoma
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Melanoma
5
Leukemia, Myeloid, Acute
5
Colorectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Lung Neoplasms
4
Liposarcoma
4
Multiple Myeloma
3
Head and Neck Neoplasms
3
Glioblastoma
3
Endometrial Neoplasms
3
Colonic Neoplasms
3
Breast Diseases
3
Brain Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Neoplasm, Residual
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Inflammation
2
Estrogen Receptor-positive Breast Cancer
2
Esophageal Squamous Cell Carcinoma
2
Interventions
apixaban
5
Heparin, Low-Molecular-Weight
4
Enoxaparin
4
Dalteparin
4
Rivaroxaban
3
Blood Specimen Collection
3
Warfarin
2
Injections
2
Aspirin
2
Anticoagulants
2
salicylhydroxamic acid
1
palbociclib
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
enoxaparin sodium
1
edoxaban
1
bemiparin
1
X-Rays
1
Ultrasonography
1
Tinzaparin
1
Technetium Tc 99m Sulfur Colloid
1
Standard of Care
1
Simvastatin
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Phlebotomy
1
Paclitaxel
1
Observation
1
Musculoskeletal Manipulations
1
Hydroxyurea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Thrombosis
×
palbociclib
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled